MOH — authorised 24 February 2014
- Marketing authorisation holder: AMYLIN PHARMS LLC
- Status: likely_approved
🇮🇱 Myalept in Israel
MOH authorised Myalept on 24 February 2014
Marketing authorisation
Myalept in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Israel
Frequently asked questions
Is Myalept approved in Israel?
Yes. MOH authorised it on 24 February 2014.
Who is the marketing authorisation holder for Myalept in Israel?
AMYLIN PHARMS LLC holds the Israeli marketing authorisation.